Metropolitan Life Insurance Co. NY trimmed its stake in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 67.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,452 shares of the medical instruments supplier’s stock after selling 73,398 shares during the quarter. Metropolitan Life Insurance Co. NY’s holdings in DENTSPLY SIRONA were worth $2,334,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently bought and sold shares of XRAY. Generation Investment Management LLP grew its position in shares of DENTSPLY SIRONA by 115.6% in the 4th quarter. Generation Investment Management LLP now owns 9,011,670 shares of the medical instruments supplier’s stock worth $593,238,000 after buying an additional 4,831,112 shares during the last quarter. Viking Global Investors LP grew its position in shares of DENTSPLY SIRONA by 51.9% in the 4th quarter. Viking Global Investors LP now owns 5,397,707 shares of the medical instruments supplier’s stock worth $355,331,000 after buying an additional 1,844,190 shares during the last quarter. Alyeska Investment Group L.P. grew its position in shares of DENTSPLY SIRONA by 223.7% in the 3rd quarter. Alyeska Investment Group L.P. now owns 2,271,534 shares of the medical instruments supplier’s stock worth $135,860,000 after buying an additional 1,569,746 shares during the last quarter. Frontier Capital Management Co. LLC bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $60,449,000. Finally, Jackson Square Partners LLC grew its position in shares of DENTSPLY SIRONA by 15.6% in the 3rd quarter. Jackson Square Partners LLC now owns 6,334,906 shares of the medical instruments supplier’s stock worth $378,890,000 after buying an additional 855,199 shares during the last quarter. Institutional investors and hedge funds own 96.80% of the company’s stock.
A number of equities research analysts have recently weighed in on the company. HC Wainwright set a $63.00 price objective on DENTSPLY SIRONA and gave the stock a “hold” rating in a research report on Monday, March 5th. Barclays assumed coverage on DENTSPLY SIRONA in a research report on Thursday, March 8th. They issued an “equal weight” rating and a $62.00 price objective on the stock. JPMorgan Chase & Co. cut their price objective on DENTSPLY SIRONA from $75.00 to $70.00 and set an “overweight” rating on the stock in a research report on Monday, March 5th. Barrington Research reiterated an “outperform” rating and issued a $70.00 price objective (down from $73.00) on shares of DENTSPLY SIRONA in a research report on Monday, March 5th. Finally, Credit Suisse Group cut their price objective on DENTSPLY SIRONA from $73.00 to $69.00 and set an “outperform” rating on the stock in a research report on Friday, March 2nd. Three analysts have rated the stock with a sell rating, four have assigned a hold rating and nine have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $67.43.
DENTSPLY SIRONA stock opened at $50.71 on Friday. The company has a market capitalization of $11,530.19, a P/E ratio of 19.06, a PEG ratio of 2.21 and a beta of 1.21. The company has a debt-to-equity ratio of 0.24, a current ratio of 2.10 and a quick ratio of 1.45. DENTSPLY SIRONA Inc has a one year low of $50.62 and a one year high of $68.98.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, March 1st. The medical instruments supplier reported $0.82 EPS for the quarter, beating the Zacks’ consensus estimate of $0.81 by $0.01. The company had revenue of $1.09 billion during the quarter, compared to analysts’ expectations of $1.06 billion. DENTSPLY SIRONA had a positive return on equity of 8.35% and a negative net margin of 39.39%. The firm’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.67 EPS. analysts expect that DENTSPLY SIRONA Inc will post 2.75 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 13th. Stockholders of record on Thursday, March 29th will be paid a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date of this dividend is Wednesday, March 28th. DENTSPLY SIRONA’s payout ratio is presently -5.09%.
COPYRIGHT VIOLATION WARNING: This piece was published by Ticker Report and is owned by of Ticker Report. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://www.tickerreport.com/banking-finance/3299848/metropolitan-life-insurance-co-ny-sells-73398-shares-of-dentsply-sirona-inc-xray.html.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.